feed,title,long_url,short_url
SeekingAlpha,Regeneron/Sanofi stops late-stage Libtayo study early after improvement in survival in NSCLC patients,https://seekingalpha.com/news/3725803,
SeekingAlpha,"BrightView EPS beats by $0.01, beats on revenue",https://seekingalpha.com/news/3725802,
